chr12-104334752-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001093771.3(TXNRD1):c.1746+420G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.906 in 152,238 control chromosomes in the GnomAD database, including 62,794 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.91 ( 62794 hom., cov: 32)
Consequence
TXNRD1
NM_001093771.3 intron
NM_001093771.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.682
Genes affected
TXNRD1 (HGNC:12437): (thioredoxin reductase 1) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes an ubiquitously expressed, cytosolic form of TrxR, which functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternative splicing, primarily at the 5' end, results in transcript variants encoding same or different isoforms, including a glutaredoxin-containing isoform that is predominantly expressed in testis. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.971 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.906 AC: 137880AN: 152120Hom.: 62746 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
137880
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.906 AC: 137983AN: 152238Hom.: 62794 Cov.: 32 AF XY: 0.902 AC XY: 67141AN XY: 74420 show subpopulations
GnomAD4 genome
AF:
AC:
137983
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
67141
AN XY:
74420
Gnomad4 AFR
AF:
AC:
0.978827
AN:
0.978827
Gnomad4 AMR
AF:
AC:
0.825874
AN:
0.825874
Gnomad4 ASJ
AF:
AC:
0.931988
AN:
0.931988
Gnomad4 EAS
AF:
AC:
0.854826
AN:
0.854826
Gnomad4 SAS
AF:
AC:
0.914523
AN:
0.914523
Gnomad4 FIN
AF:
AC:
0.843308
AN:
0.843308
Gnomad4 NFE
AF:
AC:
0.891669
AN:
0.891669
Gnomad4 OTH
AF:
AC:
0.911932
AN:
0.911932
Heterozygous variant carriers
0
649
1297
1946
2594
3243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3045
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at